SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12 (k) of the Securities Exchange Act of 1934 ("Exchange Act"), of over-the-counter trading of the securities of HealthTech International, Inc. ("HealthTech"). The trading suspension began at 9:30 a.m. on November 17, 1997 and terminates at 11:59 p.m. on December 1, 1997. HealthTech is based in Mesa, Arizona and operates health clubs in Texas, Oregon and Arizona.
The Commission temporarily suspended trading in the securities of HealthTech because of questions that have been raised about the adequacy and accuracy of publicly disseminated information about HealthTech concerning, among other things, its financial condition and acquisitions made by the company.
The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by HealthTech. .
Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the Rule. If any broker or dealer has any questions as to whether or not he has complied with the Rule, he should not enter any quotation but should immediately contact the staff of the Securities and Exchange Commission in Washington, D.C. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to HealthTech's securities until such time as he has familiarized himself with the Rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the Rule, the Commission will consider the need for enforcement action.
If any broker-dealer or other person has any information which may relate to this matter, they should contact Daniel Goldstein, Assistant Regional Director of the Northeast Regional Office of the Securities and Exchange Commission, at (212)748-8066.http://www.sec.gov/litigation/suspensions/34-39330.htm